The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

Melrose CEO Peter Dilnot has overtaken AstraZeneca’s Pascal Soriot as the UK’s highest-paid FTSE 100 boss after a £45m payout, fuelling fresh debate over executive pay gaps.

GlaxoSmithKline Pharmaceuticals' shares fell by 2% in Thursday's morning trade, reflecting a bearish market sentiment. The company is currently trading at Rs 2,680.10 per share.

Television ad volumes dip 10% in 2025, FMCG dominates, top ten advertisers contribute 47% share, GECs lead in ads.

Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...

The Food & Beverage sector maintained its leadership position with a 22% share of total ad volumes, followed by the personal ...

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

U.S. District Judge Paul Diamond, of the Eastern District of Pennsylvania, said he was considering sanctions against Steve ...